Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis
- 18 December 2023 - 1 mins read
The purpose of this study is to determine the efficacy and safety of a single dose of 750 U of Dysport compared to placebo for the improvement in the daily incontinence episode frequency for each administration mode in subjects suffering from neurogenic detrusor overactivity following spinal cord injury or multiple sclerosis.
18 December 2023
1 mins read
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
18 December 2023
1 mins read
Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow’s Feet)
18 December 2023
1 mins read
Somatuline Autogel: Acromegaly Self/Partner Injection Study
18 December 2023
1 mins read
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
18 December 2023
1 mins read
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
18 December 2023
1 mins read
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
18 December 2023
1 mins read
Dysport® Adult Lower Limb Spasticity Follow-on Study
18 December 2023
1 mins read
Dysport® Pediatric Lower Limb Spasticity Study
18 December 2023
1 mins read
Dysport® Adult Lower Limb Spasticity Study
18 December 2023
1 mins read